Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-22-008875
Filing Date
2022-11-25
Accepted
2022-11-23 17:53:22
Documents
70
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K thct_10k.htm   iXBRL 10-K 1032395
2 CERTIFICATION thct_ex311.htm EX-31.1 10691
3 CERTIFICATION thct_ex312.htm EX-31.2 10360
4 CERTIFICATION thct_ex321.htm EX-32.1 4171
5 CERTIFICATION thct_ex322.htm EX-32.2 4196
11 thct_10kimg1.jpg GRAPHIC 4743
  Complete submission text file 0001477932-22-008875.txt   4369754

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA thct-20220731.xsd EX-101.SCH 51911
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20220731_lab.xml EX-101.LAB 264323
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20220731_cal.xml EX-101.CAL 45413
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20220731_pre.xml EX-101.PRE 219538
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20220731_def.xml EX-101.DEF 127306
64 EXTRACTED XBRL INSTANCE DOCUMENT thct_10k_htm.xml XML 549309
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-55994 | Film No.: 221417268
SIC: 3523 Farm Machinery & Equipment